Migraine Functional Impact Questionnaire (MFIQ)
Understand the multifaceted impact a migraine has on patient functionality
A migraine has a significant impact on multiple aspects of daily living for millions of people around the world. The Migraine Functional Impact Questionnaire (MFIQ) is a 26-item self-report questionnaire, developed to measure the subjective impact of migraine on physical functioning (everyday activities and physical impairment), as well as social and emotional functioning in the past seven days. It is intended for use in adults (age 18 or older) with episodic migraine (EM) or chronic migraine (CM), with or without aura.
The MFIQ was designed to be completed once a week to capture the week-to-week variability of the impact of migraine. A seven-day recall period captures the variability of migraine symptoms and impacts, while being less burdensome than a daily assessment and reducing potential recall bias associated with longer recall intervals.
This measure was developed using methods consistent with the regulatory guidance on patient-reported outcome (PRO) measures to support label claims about the benefit of treatments (FDA Guidance, 2009).
The MFIQ includes domains to assess the impact of migraine on multiple aspects of functioning:
Licensing information
As the contracted agency approved by the MFIQ copyright holder (Amgen Inc.) to license and distribute the MFIQ, we uphold our responsibility to protect the integrity of the MFIQ as it is distributed for use, including development of translations and adaptations.
A user agreement is required for all requests to use the MFIQ in research and use is granted for a single study only. Fees for licensure vary depending on the type of user making the request and nature of the research. To inquire about terms and fees for licensure to use the MTIQ, please choose the appropriate affiliation below to submit your interest, and you will be contacted by a COA expert with information relevant to your needs.
Translations available
The MFIQ is available in paper-pencil format and ePRO format in multiple languages.
Scroll the table to view available translations.
| Language | Country |
|---|---|
| Bengali | India |
| Bulgarian | Bulgaria |
| Chinese (Simplified) | China |
| Czech | Czech Republic |
| Danish | Denmark |
| Dutch Universal | Belgium/Netherlands |
| English Universal | Australia/Canada/United Kingdom/United States |
| Finnish | Finland |
| French Universal | Belgium/Canada/France/Switzerland |
| German Universal | Austria/Germany/Switzerland |
| Greek | Greece |
| Hindi | India |
| Hungarian | Hungary |
| Icelandic | Iceland |
| Italian Universal | Italy/Switzerland |
| Japanese | Japan |
| Kannada | India |
| Korean | S. Korea |
| Malayalam | India |
| Marathi | India |
| Norwegian | Norway |
| Polish | Poland |
| Portuguese Universal | Portugal |
| Romanian | Romania |
| Russian Universal | Russia |
| Slovak | Slovakia |
| Spanish Universal | Argentina/Colombia/Mexico/Spain/United States |
| Swedish | Sweden |
| Tamil | India |
| Telegu | India |
| Turkish | Turkey |
While the list of available translations is extensive, the process for any additional translations needed is outlined below:
- We must conduct all translation work using our preferred vendors who have a history with this COA
- Standardized methods for COA translation are followed and certification letters are provided
- The MFIQ developers will conduct the developer review to assure any new translations are conceptually equivalent across all translations
- Please provide your language needs on your submission form, and you will be provided with a cost estimate and timeline with our reply to the details of your project
Explore the MFIQ resources
The MFIQ is supported by professional publications and scientific presentations.